The Role of the DNA Damage Checkpoint Pathway in Intraductal Papillary Mucinous Neoplasms of the Pancreas

作者: Yoshihiro Miyasaka , Eishi Nagai , Hiroshi Yamaguchi , Kei Fujii , Takahiro Inoue

DOI: 10.1158/1078-0432.CCR-07-0032

关键词:

摘要: Purpose: Intraductal papillary mucinous neoplasms (IPMN) are known to show a transition from adenoma carcinoma accompanied by several molecular abnormalities. ATM-Chk2-p53 DNA damage checkpoint activation, which is involved in prevention of the progression tumors, was analyzed evaluate role IPMNs. Experimental Design: One hundred and twenty-eight IPMNs were classified into four groups (intraductal adenoma, borderline IPMN, noninvasive intraductal carcinoma, invasive carcinoma) stained immunohistochemically using antibody for Thr 68 -phosphorylated Chk2. Expression ATM, Chk2, p21 WAF1 accumulation p53 also analyzed. Results: Chk2 phosphorylation shown all adenomas showed significant decreasing trend with atypia ( P exhibited tendency Conclusion: Our findings indicate that activation occurs early stage prevents their progression. It suggested disturbance pathway due inactivation or mutation contributes carcinogenesis

参考文章(39)
Ralph H. Hruban, Yoshihiko Tokusashi, Edward Gabrielson, Hiroaki Fujii, Shinichi Kasai, Naoyuki Miyokawa, Mitsuhiro Inagaki, Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas. American Journal of Pathology. ,vol. 151, pp. 1447- 1454 ,(1997)
Bert Vogelstein, David Lane, Arnold J. Levine, Surfing the p53 network Nature. ,vol. 408, pp. 307- 310 ,(2000) , 10.1038/35042675
Sandra A. Biankin, James G. Kench, Susan M. Henshall, C.-Soon Lee, Adrienne L. Morey, Darren R. Head, Andrew V. Biankin, Robert L. Sutherland, Thomas B. Hugh, Overexpression of p21WAF1/CIP1 is an Early Event in the Development of Pancreatic Intraepithelial Neoplasia Cancer Research. ,vol. 61, pp. 8830- 8837 ,(2001)
Helen Piwnica-Worms, Christine E. Canman, Joon Young Ahn, Julie K. Schwarz, Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation Cancer Research. ,vol. 60, pp. 5934- 5936 ,(2000)
Michael B. Kastan, Jiri Bartek, Cell-cycle checkpoints and cancer Nature. ,vol. 432, pp. 316- 323 ,(2004) , 10.1038/NATURE03097
Tomokazu Hoshi, Masato Imai, Katsuhiro Ogawa, Frequent K‐ras mutations and absence of p53 mutations in mucin‐producing tumors of the pancreas Journal of Surgical Oncology. ,vol. 55, pp. 84- 91 ,(1994) , 10.1002/JSO.2930550205
Fabrizio d'Adda di Fagagna, Philip M. Reaper, Lorena Clay-Farrace, Heike Fiegler, Philippa Carr, Thomas von Zglinicki, Gabriele Saretzki, Nigel P. Carter, Stephen P. Jackson, A DNA damage checkpoint response in telomere-initiated senescence Nature. ,vol. 426, pp. 194- 198 ,(2003) , 10.1038/NATURE02118
Zhenbang Chen, Lloyd C. Trotman, David Shaffer, Hui-Kuan Lin, Zohar A. Dotan, Masaru Niki, Jason A. Koutcher, Howard I. Scher, Thomas Ludwig, William Gerald, Carlos Cordon-Cardo, Pier Paolo Pandolfi, Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis Nature. ,vol. 436, pp. 725- 730 ,(2005) , 10.1038/NATURE03918
Michael G House, MingZhou Guo, Christine Iacobuzio-Donahue, James G Herman, Molecular progression of promoter methylation in intraductal papillary mucinous neoplasms (IPMN) of the pancreas Carcinogenesis. ,vol. 24, pp. 193- 198 ,(2003) , 10.1093/CARCIN/24.2.193
Shuhei Matsuoka, Mingxia Huang, Stephen J Elledge, Linkage of ATM to Cell Cycle Regulation by the Chk2 Protein Kinase Science. ,vol. 282, pp. 1893- 1897 ,(1998) , 10.1126/SCIENCE.282.5395.1893